DOCSLIB.ORG

Vade-Mecum from a to Z Companies Whose Shares Are Listed on Euronext Brussels 2019 Edition 2 | Introduction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Vade-Mecum from a to Z Companies Whose Shares Are Listed on Euronext Brussels 2019 Edition 2 | Introduction Vade-Mecum from A to Z Companies whose shares are listed on Euronext Brussels 2019 Edition 2 | Introduction A company listed on a stock exchange market is subject companies whose financial instruments are exclusively to various specific requirements which go beyond admitted to trading on a foreign regulated market, even information obligations. Compliance with such stock if the company is incorporated under Belgian law. exchange matters is a complex and demanding task, Notably, we have already referred to the relevant entailing a series of legal and regulatory rules. provisions of the draft law reforming the Belgian To guide companies through these complexities, Companies Code (“Prospective New Belgian Euronext Brussels and Jones Day Brussels have Companies Code”), in anticipation of its adoption. prepared this “Vade-Mecum from A to Z”. The Code is pending the Parliament’s final approval, The Vade-Mecum provides an overview of the main legal following its earlier approval by the Parliament’s Justice requirements applicable to a Belgian company after its Commission in October 2018. shares have been admitted to trading on the Euronext This Vade-Mecum is published for information purposes | 3 Brussels regulated market. only and is non-exhaustive. It is not intended to replace However, the Vade-Mecum does not address any either (i) regulatory texts or other circulars issued requirements concerning: by the FSMA as the regulatory authority, or (ii) the Euronext Rule Book, whose provisions are cited for the rules applicable to the first admission of securities further reference by our readers. Euronext Brussels on Euronext Brussels regulated market; and Jones Day Brussels are not responsible for any gap companies whose securities are admitted to the or conflict of interpretation between the Vade-Mecum other markets organized by Euronext Brussels, and in and legal texts. In case of doubt, we invite readers to particular, multilateral trading facilities (or MTFs) such consult the legal and regulatory texts and, as needed, as Euronext Growth and Euronext Access; to seek assistance from their usual points of contact at Euronext Brussels, the FSMA or Jones Day Brussels. companies whose debt securities (such as bonds) are The information is updated as at 1 January 2019 and admitted to trading on the Euronext Brussels regulated presented in alphabetical order. All initially capitalized market; terms used in this Vade-Mecum are covered in its various chapters. Table of content A | Addresses | 7 Audit Committee B | Belgian State Gazette | 11 C | Calendar Euronext 2019 | 13 Closed Period Conflicts of interest Corporate Events Corporate Governance D | Dividends, Coupon Detachment and Record Date | 19 4 | Double-voting right E | Embargo | 25 F | Form of the shares | 27 G | Gender Diversity | 29 General Meeting of Shareholders I | Inside Information | 41 Insider Lists L | LEI | 45 Listed Company M | Major Holdings | 49 Management Report Table of content N | Non-Financial Information | 53 P | PDMRs (Persons discharging managerial responsibility) | 55 Periodic Information Permanent Information R | Regulated Information | 63 Remuneration of Management Remuneration and Nomination Committees S | Share Buyback | 71 Statutory Auditor Suspension of the shares | 5 T | Take-over Bids (voluntary bid, mandatory bid, squeeze-out and sell-out) | 75 W | Website of the Listed Company | 79 Annex | Euronext | 83 Jones Day 6 | A Aa | Addresses Euronext Brussels 1 Rue du Marquis / Markiesstraat 1, 1000 Brussels, Belgium Tel +32 2 620 15 00 E-mail: [email protected] www.euronext.com FSMA Rue du Congrès 12-14 / Congresstraat 12-14, 1000 Brussels, Belgium 8 | Tel +32 2 220 52 11 www.fsma.be/fr/contact Jones Day Rue de la Régence 4 / Regentschapsstraat 4, 1000 Brussels, Belgium Tel +32 2 645 14 11 www.jonesday.com/brussels/ Aa | Audit Committee AUDIT COMMITTEE In such case, the board of directors shall perform the duties of the Audit Committee. Listed companies must have an Audit Committee within their board of directors whose members must have The Audit Committee’s main tasks are to monitor collective competence in the company’s field of activity. the process of preparing financial information, the One member must also have particular accounting effectiveness of the company’s internal control systems and audit skills. The president is appointed by the and risk management regarding procedures concerning committee members. the preparation and processing of accounting and financial information, and to make recommendations The Audit Committee is composed of non-executive to the company’s board of directors for appointing the members of the board of directors, at least one of whom Statutory Auditor. is independent. The 2009 Belgian Corporate Governance | 9 Code also adds that at least a majority of the Audit In addition, the Audit Committee is also responsible Committee members must be independent. This rule for providing the board of directors with information applies under the “comply or explain” principle and the on the results of the statutory audit of the annual corporate governance statement. accounts, and explanations on how the statutory audit of the annual accounts has contributed to the integrity Listed Companies which, on a consolidated basis, meet of the financial information and the role that the Audit at least two of the following criteria (“Small Listed Committee played in this process. Companies”) need not establish an audit committee: average number of employees during the relevant financial year of less than 250; balance sheet total of less than or equal to EUR 43,000,000; and annual net turnover of less than or equal to EUR 50,000,000. 10 | B | 11 Bb | Belgian State Gazette BELGIAN STATE GAZETTE with proof of payment, must be filed with the clerk of the competent Commercial Court, which will also record any The Belgian State Gazette (“Moniteur belge” / “Belgisch amendment to the company’s details in the Crossroads Staatsblad”) ensures the publication of all official acts Databank for Enterprises. Publication of resolutions take and notices concerning legal entities, including notices place within 15 days of filing with Commercial Court. for the General Meeting of Shareholders. The Gazette is published electronically every business day. The publication forms and all information on payment Without prejudice to the other provisions applicable formalities can be obtained on the Belgian State Gazette to the publication of notices for the General Meeting website at: of Shareholders (notably in the media, see “General https://justice.belgium.be/fr/moniteur_belge Meeting of Shareholders”), Listed Companies must 12 | or https://justitie.belgium.be/nl/belgisch_staatsblad publish notices for their general meetings in the Belgian State Gazette at least 30 calendar days prior to the date of such meeting. The text of the notice must be addressed in word format by email to the following address: [email protected] or [email protected]. Publication then takes place within three to five business days. Invoices covering publications costs will be sent by the Belgian State Gazette to the relevant company after publication of the notice. Corporate resolutions requiring publication must be published by extract in the Belgian State Gazette. Publication allows for enforceability of a resolution vis-à-vis third parties. Publication costs must be paid in advance of publication. The publication forms, along C | 13 Cc | Calendar Euronext 2019 - Closed Period CALENDAR EURONEXT 2019 CLOSED PERIOD The Euronext markets will be open from Monday to The Market Abuse Regulation (“MAR”) prohibits Friday throughout 2019 except on the following days: any person holding Inside Information (see “Inside Information”) from carrying out or attempting to carry Tuesday 1 January 2019 out insider trading by acquiring or selling (directly or (New Year’s Day) indirectly, for his own account or for the account of a third party) financial instruments to which this information Friday 19 April 2019 relates or by cancelling or amending orders previously (Good Friday) placed on the Listed Company’s financial instruments. Monday 22 April 2019 Similarly, it is prohibited to recommend that another 14 | (Easter Monday) person engages in insider trading or to induce another person to engage in insider trading or to disclose Inside Wednesday 1 May 2019 Information to any other person except in the normal (Labour Day) course of a profession or duties. Wednesday 25 December 2019 (Christmas Day) During a Closed Period of 30 calendar days before the announcement of a year-end report or any interim Thursday 26 December 2019 financial report that the company is required to make (Boxing Day) public, any person discharging managerial responsibilities Information can also be found at (“PDMR”, see “PDMRs”) within a Listed Company may www.euronext.com/trading-calendars-hours not conduct any transactions on his own account or for the account of a third party, directly or indirectly, relating to the shares or debt instruments of the company or to derivatives or other financial instruments linked to them. However, this prohibition may be lifted in case of exceptional circumstances assessed on a case- Cc | Closed Period - Conflicts of interest by-case basis, such as severe financial difficulty or in must describe the context and scope of the decision function of characteristics of the trading involved (e.g. or transaction and must justify the decision and the for transactions related to an employee
Load more

Recommended publications
  • Content Requirements Checklist for Information Document
    CONTENT REQUIREMENTS CHECKLIST FOR INFORMATION DOCUMENT ADMISSION TO TRADING OF SHARES ON EURONEXT GROWTH OPERATED BY OSLO BØRS CONTENT REQUIREMENTS CHECKLIST FOR INFORMATION DOCUMENT No. Description of requirement Reference to section(s) in the information document 2.1 General information to be included in the Information Document1 The following disclaimer shall be put on the first page of the Information Document: “Euronext Growth is a market operated by Euronext. Companies on Euronext Growth, a multilateral trading facility (MTF), are not subject to the same rules as companies on a Regulated Market (a main market). Instead they are subject to a less extensive set of rules and regulations adjusted to small growth companies. The risk in investing in a company on Euronext Growth may therefore be higher than investing in a company on a Regulated Market. Investors should take this into account when making investment decisions.” The following statement shall be put on the first page of the Information Document: “The present Information Document does not constitute a prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71. The present Information Document has been drawn up under the responsibility of the Issuer. It has been reviewed by the Euronext Growth Advisor and has been subject to an appropriate review of its completeness, consistency and comprehensibility by Euronext.” The following liability statement from the persons responsible 2for the Information Document shall be included in the Information Document: 1 Cf.
    [Show full text]
  • Execution Venues List
    Execution Venues List This list should be read in conjunction with the Best Execution policy for Credit Suisse AG (excluding branches and subsidiaries), Credit Suisse (Switzerland) Ltd, Credit Suisse (Luxembourg) S.A, Credit Suisse (Luxembourg) S.A. Zweigniederlassung Österreichand, Neue Aargauer Bank AG published at www.credit-suisse.com/MiFID and https://www.credit-suisse.com/lu/en/private-banking/best-execution.html The Execution Venues1) shown enable the in scope legal entities to obtain on a consistent basis the best possible result for the execution of client orders. Accordingly, where the in scope legal entities may place significant reliance on these Execution Venues. Equity Cash & Exchange Traded Funds Country/Liquidity Pool Execution Venue1) Name MIC Code2) Regulated Markets & 3rd party exchanges Europe Austria Wiener Börse – Official Market WBAH Austria Wiener Börse – Securities Exchange XVIE Austria Wiener Börse XWBO Austria Wiener Börse Dritter Markt WBDM Belgium Euronext Brussels XBRU Belgium Euronext Growth Brussels ALXB Czech Republic Prague Stock Exchange XPRA Cyprus Cyprus Stock Exchange XCYS Denmark NASDAQ Copenhagen XCSE Estonia NASDAQ Tallinn XTAL Finland NASDAQ Helsinki XHEL France EURONEXT Paris XPAR France EURONEXT Growth Paris ALXP Germany Börse Berlin XBER Germany Börse Berlin – Equiduct Trading XEQT Germany Deutsche Börse XFRA Germany Börse Frankfurt Warrants XSCO Germany Börse Hamburg XHAM Germany Börse Düsseldorf XDUS Germany Börse München XMUN Germany Börse Stuttgart XSTU Germany Hannover Stock Exchange XHAN
    [Show full text]
  • Are Retail Investors Less Aggressive on Small Price Stocks?
    Are retail investors less aggressive on small price stocks? Carole M´etais∗ Tristan Rogery January 13, 2021 Abstract In this paper, we investigate whether number processing impacts the limit orders of retail investors. Building on existing literature in neuropsychology that shows that individuals do not process small numbers and large numbers in the same way, we study the influence of nominal stock price level on order aggressiveness. Using a unique database that allows us to identify order and trade records issued by retail investors on Euronext Paris, we show that retail investors, when posting non-marketable orders, are less aggressive on small price stocks than on large price stocks. This difference in order aggressiveness is not explained by differences in liquidity and other usual drivers of order aggressiveness. We provide additional evidence by showing that no such difference exists for limit orders of high frequency traders (HFTs) over the same period and the same sample of stocks. This finding confirms that our results are driven by a behavioral bias and not by differential market dynamics between small price stocks and large price stocks. ∗LaRGE Research Center, University of Strasbourg { Mailing address: 61 Avenue de la For^etNoire, 67000 Strasbourg FRANCE { Email: [email protected]. I acknowledge support from the French State through the National Agency for Research under the program Investissements d'Avenir ANR-11-EQPX- 006. yDRM Finance, Universit´eParis-Dauphine, PSL Research University { Mailing address: Place du Mar´echal de Lattre de Tassigny, 75775 Paris Cedex 16 FRANCE { Email: [email protected] 1 1 Introduction While conventional finance theory posits that nominal stock prices are irrelevant for firm valuation, a number of papers provide empirical evidence that nominal prices do impact investor behavior.
    [Show full text]
  • EURONEXT GROWTH MARKETS RULE BOOK Part II: Additional Rules for the Euronext Growth Market Operated by Euronext Dublin
    EURONEXT GROWTH MARKETS RULE BOOK Part II: Additional rules for the Euronext Growth Market operated by Euronext Dublin ISSUE DATE: 9TH NOVEMBER 2020 EFFECTIVE DATE: 30 NOVEMBER 2020 TABLE OF CONTENTS Definitions ...................................................................................................................................................................... 3 1. Conditions for Admission to the Euronext Growth Market operated by Euronext Dublin .................................... 8 SPECIAL CONDITIONS FOR CERTAIN APPLICANTS .......................................................................................................... 8 2. Lock-ins for new businesses ................................................................................................................................... 8 3. Investing companies ............................................................................................................................................... 9 APPLICATION PROCEDURE ........................................................................................................................................... 10 4. Pre-admission announcement ............................................................................................................................. 10 5. Information document ......................................................................................................................................... 10 6. Further information documents .........................................................................................................................
    [Show full text]
  • Information Document Euronext Growth
    INFORMATION DOCUMENT EURONEXT GROWTH FEBRUARY 21st, 2020 Facephi.com: EURONEXT Growth 3 FacePhi Facephi Biometría, S.A. C/ México, 20 Edificio Marsamar, 3ºC (03008) Alincante-SPAIN “Registro Mercantil de Alicante al número:” A- 54659313 Hereinafter “FacePhi” or “The Company” INFORMATION DOCUMENT EURONEXT GROWTH PARIS DIRECT ADMISSION TO NEGOTIATION ADVERTISSEMENT Euronext Growth is a market operated by Euronext. Companies on Euronext Growth are not subject to the same rules as companies on a Regulated Market (a main market). Instead they are subject to a less extensive set of rules and regulations adjusted to small growth companies. The risk in investing in a company on Euronext Growth may therefore be higher than investing in a company on a Regulated Market. The present Information Document does not constitute a prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament abd of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71. The present Information Document has been drawn up under the responsibility of FACEPHI. It has been reviewed by PMS, Asesores Registrados, S.L. and has been subject to an appropriate review of its completeness, consistency and comprehensibility by Euronext. We declare that, to the best of our knowledge, the information provided in this Information Document is accurate and that, to the best of our knowledge this Information Document is not subject to any (material) omissions, and that all relevant information is included in this Information Document.
    [Show full text]
  • Pixium Vision Announces a Financing Agreement for a Maximum Amount of €10 Million, Issuing a First Tranche of € 1.25 Million, for the Development of Its Prima System
    PRESS RELEASE Pixium Vision announces a financing agreement for a maximum amount of €10 million, issuing a first tranche of € 1.25 million, for the development of its Prima system • Financing of the development of the Prima system on the back of its excellent clinical results • Subsequent drawdowns possible depending on financing needs • Subsequent drawdowns conditional to approval of needed resolutions at the AGM to be held on December 12, 2019 Paris, 6 November 2019 – 7.00 am CEST– Pixium Vision (FR0011950641 - PIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, announces that it has concluded a financing agreement with the US-based investor, specialized in healthcare, European Select Growth Opportunities Fund (the “Investor”) for an issue of bonds repayable in cash and/or new shares (the “Bonds”) for a maximum nominal amount of €10 million, without interest, and without share warrants, over a period of no more than 30 months. ESGO supports Pixium Vision’s long-term development and has committed to take part in a capital increase in the event such a transaction is carried out. “We welcome this financing agreement and the trust ESGO has placed in us. Thanks to this flexible financial instrument, which significantly strengthens our financial outlook, we will actively pursue the development of our Prima system. We recently reached an important milestone now that the first patients implanted are equipped with second-generation glasses. These glasses combine residual natural vision and bionic vision. This is the first time such clinical success has been demonstrated and can be correlated with a potential improvement in quality of life.
    [Show full text]
  • Liste: Börsenmäßige Handelsplätze
    Liste der anerkannten börsenmäßigen Handelsplätze i.S.v. § 12 Abs. 1 Allgemeine Geschäftsbedingungen der Deutsche Börse AG für den Freiverkehr an der Frankfurter Wertpapierbörse mit Gültigkeit ab dem 03. Mai 2021 Regulierte Hauptmärkte folgender Börsen Abu Dhabi Securities Exchange Cyprus Stock Exchange NASDAQ Riga Amman Stock Exchange Delhi Stock Exchange NASDAQ Stockholm Aquis Stock Exchange Dubai Financial Market NASDAQ Tallinn Armenia Stock Exchange Egyptian Exchange NASDAQ Vilnius Athens Stock Exchange Euronext Amsterdam National Stock Exchange of India Australian Securities Exchange Euronext Brussels New Zealand Exchange B3 - Brasil, Bolsa, Balcão Euronext Dublin Nigerian Stock Exchange Bahrain Bourse Euronext Lisbon NYSE American Banja Luka Stock Exchange Euronext London NYSE Chicago Bermuda Stock Exchange Euronext Oslo NYSE New York Bolsa de Barcelona Euronext Paris Osaka Exchange Bolsa de Bilbao Frankfurter Wertpapierbörse PFTS Stock Exchange Bolsa de Comercio de Buenos Aires Fukuoka Stock Exchange Philippine Stock Exchange Bolsa de Madrid Ho Chi Minh Stock Exchange Prague Stock Exchange Bolsa de Valencia Hong Kong Stock Exchanges Qatar Stock Exchange Bolsa de Valores de Colombia Indonesia Stock Exchange Santiago Stock Exchange Bolsa de Valores de Lima Japan Exchange Group Sapporo Securities Exchange Bolsa Mexicana de Valores Johannesburg Stock Exchange Saudi Stock Exchange Bombay Stock Exchange Kazakhstan Stock Exchange Shanghai Stock Exchange Borsa Istanbul Korea Exchange Shenzhen Stock Exchange Borsa Italiana Ljubljana Stock
    [Show full text]
  • Vade-Mecum 2021 Companies with Shares Listed on Euronext Brussels the Main Legal Obligations from a to Z This VADE-MECUM Is a Topical Document
    Vade-Mecum 2021 Companies with shares listed on Euronext Brussels The main legal obligations from A to Z This VADE-MECUM is a topical document. It combines most of the texts, positions and recommendations pertaining to the recurrent obligations for companies whose securities are listed on Euronext (regulated market). This information was updated on January 14th, 2021 | 3 and presented in alphabetical order, without claiming to be exhaustive. Introduction Introduction A company listed on a stock exchange market is subject to various specific requirements which Companies incorporated prior to the BCCA’s entry into force will benefit from a transitional go beyond information obligations. period running from January 1, 2020 to January 1, 2024. However, mandatory and public policy rules are applicable as from January 1, 2020, even in the absence of any amendment to the To guide companies through these legal and regulatory rules, Euronext Brussels and Jones articles of association. Clauses contrary to these rules are also deemed void. The default rules Day Brussels have prepared this “Vade-Mecum from A to Z”. are also applicable as of this date, unless the articles of association derogate from these. The The Vade-Mecum provides an overview of the main legal requirements applicable to a Belgian articles of association must be brought into compliance with the BCCA by January 1, 2024 at company after its shares have been admitted to trading on the Euronext Brussels regulated the latest. However, already as from January 1, 2020, any amendment to articles of association market. entails an obligation to bring these into compliance with the BCCA.
    [Show full text]
  • Norse Atlantic ASA (A Public Limited Liability Company Incorporated Under the Laws of Norway)
    Information Document Norse Atlantic ASA (A public limited liability company incorporated under the laws of Norway) Admission to trading of shares on Euronext Growth Oslo ________________________________________________________ This information document (the "Information Document") has been prepared by Norse Atlantic ASA (the "Company" or "Norse Atlantic") solely for use in connection with the admission to trading of all the issued shares of the Company on Euronext Growth Oslo (the "Admission"), operated by Oslo Børs ("Euronext Growth Oslo"). As of the date of this Information Document, the Company's registered share capital is NOK 221,250,000 divided into 73,750,000 shares, each with a nominal value of NOK 3 (the "Shares"). The Shares are registered in the Norwegian Central Securities Depository (Nw.:Verdipapirsentralen) (the "VPS") in book-entry form. The Company has applied for admission to trading of its Shares on Euronext Growth Oslo and it is expected that the Shares will start trading on or about 12 April 2021 under the ticker symbol "NORSE". Euronext Growth Oslo is a market operated by Euronext. Companies on Euronext Growth Oslo, a multilateral trading facility (MTF), are not subject to the same rules as companies on a Regulated Market (a main market). Instead they are subject to a less extensive set of rules and regulations adjusted to small growth companies. The risk in investing in a company on Euronext Growth Oslo may therefore be higher than investing in a company on a Regulated Market. Investors should take this into account when making investment decisions. The present Information Document does not constitute a prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71.
    [Show full text]
  • Euronext to Acquire the Borsa Italiana Group and Create the Leading Pan-European Market Infrastructure
    CONTACT EURONEXT - Media: CONTACT EURONEXT - Investor Relations: Amsterdam +31.20.721.4133 Brussels +32.2.620.15.50 +33.1.70.48.24.17 Dublin +353 1 617 4221 Lisbon +351.210.600.614 Oslo +47 22 34 19 15 Paris +33.1.70.48.24.45 EURONEXT TO ACQUIRE THE BORSA ITALIANA GROUP AND CREATE THE LEADING PAN-EUROPEAN MARKET INFRASTRUCTURE 1 Acquisition of 100% of London Stock Exchange Group Holdings Italia S.p.A., the holding company of the Borsa Italiana Group2 for a cash consideration of €4,325 million3 The Borsa Italiana Group (€464 million revenue and €264 million EBITDA in 2019) to play a key role in the future operations, strategy and governance of the Combined Group4 as its largest revenue contributor Strong support from Cassa Depositi e Prestiti (through CDP Equity5 (“CDPE”), 100%-owned) and Intesa Sanpaolo6 as strategic investors, with long-term commitment to support the growth of the Borsa Italiana Group, to attract SMEs to the capital markets and to support Euronext’s growth ambitions Creation of the leading player in European capital markets infrastructure, strengthening Euronext’s leadership in European cash equities, while adding significant capabilities in fixed income trading and increasing post trade activities with a fully-owned, multi-asset clearing house and a scale CSD Widening of the product offering across the value chain and deepening of the liquidity pool to bring significant benefits for European capital markets and the Italian financial ecosystem Financing of the transaction fully secured by a bridge loan financing
    [Show full text]
  • COMPARISON of the EUROPEAN and the U.S. UNREGULATED STOCK MARKETS DESIGNED for SMES Imanou Akala, Sakarya University
    The International Journal of Business and Finance Research Vol. 13, No. 1, 2019, pp. 85-102 ISSN: 1931-0269 (print) www.theIBFR.com ISSN: 2157-0698 (online) COMPARISON OF THE EUROPEAN AND THE U.S. UNREGULATED STOCK MARKETS DESIGNED FOR SMES Imanou Akala, Sakarya University ABSTRACT This paper examines the state of small and medium enterprises (SMEs) in European and U.S. unregulated stock markets. The analysis compares the performance of both markets, using the weekly adjusted closing index prices of Euronext all share index, NYSE AMEX Composite Index, and the OTCM ADR Index for the 2013-2017 period. ADF, EGARCH, and ARCH tests were performed on the collected time series data, to measure and forecast index price volatility, risk and return. The results show a high level of price volatility in some periods; but a permanent effect of shocks was not observed in the long term for all the analyzed indexes. Negative shocks cause more volatility than positive shocks. However, an overall result shows that, the Euronext all share index, despite slight declines, displays an upward trend and relatively higher returns with less risk, than the NYSE AMEX Composite Index, and the OTCM ADR Index. This results reflects the better performance of the European unregulated market, compare to its U.S. counterparts. JEL: M130, G1, C120, C220 KEYWORDS: Small and Medium Enterprises, Stock Markets, Initial Public Offering, Index Prices, Financial Risk and Return INTRODUCTION lthough a significant amount of reports and studies have been conducted regarding SMEs in the American, the Asian, the European unregulated stock markets and elsewhere (Hall, 2007; OICV AIOSCO 2015; Bremus, 2015; Kiškis, Limba and Gulevičiūtė, 2016; Kentaro, 2016 and others); studies comparing SMEs’ unregulated stock markets performance to each other, locally or internationally are scarce.
    [Show full text]
  • Initial Public Offerings Law Review
    Law Review Law the Initial Public Offerings Offerings Public Initial Initial Public Offerings Law Review Third Edition Editor David J Goldschmidt Third Edition Third lawreviews © 2019 Law Business Research Ltd Initial Public Offerings Law Review Third Edition Reproduced with permission from Law Business Research Ltd This article was first published in April 2019 For further information please contact [email protected] Editor David J Goldschmidt lawreviews © 2019 Law Business Research Ltd PUBLISHER Tom Barnes SENIOR BUSINESS DEVELOPMENT MANAGER Nick Barette BUSINESS DEVELOPMENT MANAGER Joel Woods SENIOR ACCOUNT MANAGERS Pere Aspinall, Jack Bagnall ACCOUNT MANAGERS Sophie Emberson, Katie Hodgetts PRODUCT MARKETING EXECUTIVE Rebecca Mogridge RESEARCH LEAD Kieran Hansen EDITORIAL COORDINATOR Gavin Jordan HEAD OF PRODUCTION Adam Myers PRODUCTION EDITOR Helen Smith SUBEDITOR Janina Godowska CHIEF EXECUTIVE OFFICER Paul Howarth Published in the United Kingdom by Law Business Research Ltd, London 87 Lancaster Road, London, W11 1QQ, UK © 2019 Law Business Research Ltd www.TheLawReviews.co.uk No photocopying: copyright licences do not apply. The information provided in this publication is general and may not apply in a specific situation, nor does it necessarily represent the views of authors’ firms or their clients. Legal advice should always be sought before taking any legal action based on the information provided. The publishers accept no responsibility for any acts or omissions contained herein. Although the information provided
    [Show full text]